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Introduction: Oxidative stress is implicated in tissue inflammation, and plays an important role in the pathogenesis
of immune-mediated nephritis. Using the anti-glomerular basement membrane antibody-induced glomeruloneph-
ritis (anti-GBM-GN) mouse model, we found that increased expression of glutathione S-transferase Mu 2 (GSTM2)
was related to reduced renal damage caused by anti-GBM antibodies. Furthermore, mesenchymal stem cell (MSC)-
based therapy has shed light on the treatment of immune-mediated kidney diseases. The aim of this study was to
investigate if MSCs could be utilized as vehicles to deliver the GSTM2 gene product into the kidney and to evaluate
its potential therapeutic effect on anti-GBM-GN.
Methods: The human GSTM2 gene (hGSTM2) was transduced into mouse bone marrow-derived MSCs via a
lentivirus vector to create a stable cell line (hGSTM2-MSC). The cultured hGSTM2-MSCs were treated with 0.5mM
H2O2, and apoptotic cells were measured by terminal dUTP nick-end labeling (TUNEL) assay. The 129/svj mice,
which were challenged with anti-GBM antibodies, were injected with 106 hGSTM2-MSCs via the tail vein. Expression
of hGSTM2 and inflammatory cytokines in the kidney was assayed by quantitative PCR and western blotting. Renal
function of mice was evaluated by monitoring proteinuria and levels of blood urea nitrogen (BUN), and renal
pathological changes were analyzed by histochemistry. Immunohistochemical analysis was performed to measure
inflammatory cell infiltration and renal cell apoptosis.
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Results: MSCs transduced with hGSTM2 exhibited similar growth and differentiation properties to MSCs.
hGSTM2-MSCs persistently expressed hGSTM2 and resisted H2O2-induced apoptosis. Upon injection into 129/svj
mice, hGSTM2-MSCs migrated to the kidney and expressed hGSTM2. The anti-GBM-GN mice treated with
hGSTM2-MSCs exhibited reduced proteinuria and BUN (58% and 59% reduction, respectively) and ameliorated renal
pathological damage, compared with control mice. Mice injected with hGSTM2-MSCs showed alleviated renal
inflammatory cell infiltration and reduced expression of chemokine (C-C motif) ligand 2 (CCL2), interleukin (IL)-1β
and IL-6 (53%, 46% and 52% reduction, respectively), compared with controls. Moreover, hGSTM2-MSCs increased
expression of renal superoxide dismutase and catalase, which may associate with detoxifying reactive oxygen
species to prevent oxidative renal damage.
Conclusions: Our data suggest that the enhanced protective effect of GSTM2-transduced MSCs against
anti-GBM-GN might be associated with inhibition of oxidative stress-induced renal cell apoptosis and inflammation,
through over-expression of hGSTM2 in mouse kidneys.Introduction
Anti-glomerular basement membrane antibody-induced
glomerulonephritis (anti-GBM-GN) is an autoimmune
disorder in which circulating antibodies against the α-3
chain of type IV collagen bind to renal GBM and initiate
an inflammatory reaction [1,2]. Anti-GBM-GN is one of
the most severe forms of glomerulonephritis, character-
ized by crescent formation and linear glomerular de-
posits of IgG [3]. Patients usually present with rapidly
progressive glomerulonephritis, hematuria and sub-
nephrotic range proteinuria. About 40–70% of patients
develop end-stage renal disease [4].
It has been reported that oxidative stress plays an im-
portant role in the pathogenesis of anti-GBM-GN, and
is one of the major causes of tubulointerstitial injury
[5-7]. During oxidative stress, cellular metabolism pro-
duces excessive reactive oxygen species (ROS), which
modulate various physiological functions and affect
innate immunity in infectious and non-infectious in-
flammation. ROS serve as the main products of innate
immunity during the course of inflammation [8]. Over-
production of ROS, reactive nitrogen species, and react-
ive chlorine species by inflammatory cells in nephritis
can cause further tissue damage, intensify inflamma-
tion, promote apoptosis, and accelerate the progression
of nephritis [9,10]. Under physiologic conditions, there
are several anti-oxidant defense mechanisms available
to limit the oxidative damage. Superoxide dismutase
(SOD) and catalase (CAT) are the two main anti-oxidant
enzymes. SOD catalyzes the dismutation of superoxide
into oxygen and hydrogen peroxide (H2O2), with the latter
subsequently degraded to water and molecular oxygen by
CAT or glutathione peroxidase (GPX) in the presence of
reduced glutathione.
Anti-GBM-GN has been used as a model for the study
of lupus nephritis because the two conditions share
some common molecular pathways [11]. Our previous
study showed that anti-GBM antibody challenge inducedsevere GN in some mouse strains such as 129/svj,
DBA1, and NZW, whereas some other strains, such as
B6 and BALB/c, were resistant to anti-GBM challenge,
exhibiting no or very mild GN [12]. Comparing the
gene expression profiles in the mouse kidneys revealed
that a cluster of redox-related genes was differentially
expressed between anti-GBM-resistant and anti-GBM-
sensitive strains. Glutathione S-transferase Mu 2, a pro-
tein involved in detoxification of ROS, was significantly
increased in anti-GBM-resistant strains (B6 and BALB/c),
but decreased in anti-GBM-sensitive strains (129/svj,
DBA1, and NZW), suggesting that GSTM2 may play a
protective role in anti-GBM induced nephritis.
GSTM2 is a member of the glutathione S-transferase
(GST) family, which participates in detoxification of
ROS [13]. GSTs act as biotransformation enzymes, and
exist widely in various mammalian tissues, including kid-
ney. They play a major role in cellular anti-oxidant
defense mechanisms by catalyzing the reduction of po-
tentially harmful peroxides [14-16]. In order to elucidate
the potential protective role of GSTM2 in the pathogen-
esis of immune-mediated nephritis, and also to explore
possible therapeutic approaches using this molecule for
lupus nephritis, we used genetically modified mesenchy-
mal stem cells (MSCs) as carriers to deliver GSTM2 into
the kidney of anti-GBM antibody-challenged mice, and
evaluated the effects of these MSCs on anti-GBM-GN.
Materials and methods
Microarray and gene expression analysis
Microarray analysis on anti-GBM challenged mice has
been described previously [17], and the renal gene ex-
pression profiles from five mouse strains (B6, BALB/c,
129/svj, DBA1, and NZW) were deposited in the GEO
database (accession number GSE53611). The expression
value of redox-related genes was extracted from the
microarray data and compared for the different strains.
TaqMan real-time quantitative PCR (RT-qPCR) assay
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tained from microarray.
Cloning of the GSTM2 gene into a lentiviral vector
Total RNA was extracted from human K562 cells with
an RNeasy kit (Qiagen, Valencia, CA, USA) and reverse-
transcribed to generate cDNA with Superscript III using
random primer (Invitrogen, Carlsbad, CA, USA). Human
GSTM2 coding domain sequence (nucleotides 95 to 751,
contains 219 amino acids) was amplified by PCR using
the primers shown in Table 1. The hGSTM2 fragment
was cloned into multiple cloning sites (MCSs) of a lenti-
viral vector pCDH-MSCV-MCS-EF1-GFP-Puro (System
Biosciences, Mountain View, CA, USA) using XbaI and
BamHI restriction enzyme cutting sites. The resulting
recombinant (pCDH-hGSTM2) DNA was amplified
in vitro, and the sequence was verified by sequencing
analysis.
Transducing pCDH-hGSTM2 into MSCs
MSCs were isolated from B6 bone marrow and cultured
in DMEM (Sigma-Aldrich, St. Louis, MO, USA). The
cultured MSCs were grown to passage 5, and transduced
with pCDH-hGSTM2 to generate an hGSTM2-MSC cell
line using lentivector expression systems (System Biosci-
ences). Briefly, pCDH-hGSTM2 was transfected into
293TN packaging cells with packaging plasmids, and the
virus particles were collected after 48 hours of cell trans-
fection. The MSCs were infected with purified pCDH-
hGSTM2 virus, and cultured for 72 hours with addition
of 8 μg/ml polybrene (Sigma-AldrichO), then the trans-
duced cells were selected with 3 μg/ml puromycin. The
percentages of GFP-positive cells in MSCs transduced
with pCDH (vector) or pCDH-hGSTM2 were about 50%
and 25%, respectively. Cell sorting by flow cytometry
was used to enrich for the GFP-positive cells in both
pCDH-MSCs and hGSTM2-MSCs. Expression of re-
combinant hGSTM2 in MSCs was assayed by RT-qPCR
and western blotting. MSCs transduced with pCDH vec-
tor (pCDH-MSCs) were used as control. Only lower pas-
sage cells (before passage 10) were used for experiments.
MSC proliferation and differentiation assay
Proliferation
hGSTM2-MSCs were seeded in six-well plates at 104
cells/well and cultured in DMEM at 37°C with 5% CO2
for 7 days. A set of plates was removed every 24 hours,
and the cells were detached with 0.25% Trypsin-EDTA,Table 1 Primers used for PCR analysis
Direction Sequence 5′→3′
Forward GCTGCAGAATCCACAGCAAC
Reverse CGCAAGGCCCTACTTGTTGCthen the total number of cells was counted under a
microscope. Proliferation of untransduced MSCs and
pCDH-MSCs (control cells) was also assayed. Triplicate
wells were counted for each cell type at each time point.
Differentiation
The differentiation potential of hGSTM2-MSCs was
tested by assays for adipogenesis and osteogenesis.
Briefly, 2 × 104 cells were seeded in six-well plates. For
adipogenic differentiation, the cultured cells were incu-
bated in DMEM containing 50 μg/ml indomethacin, 0.1
μM dexamethasone, and 50 μg/ml L-ascorbic acid 2-
phosphate sesquimagnesium salt hydrate (all Sigma-
Aldrich). For osteogenic differentiation, the cultured
cells were incubated in medium supplemented with 10
mM β-glycerophosphate disodium salt hydrate, 50 μg/ml
L-ascorbic acid 2-phosphate sesquimagnesium salt hy-
drate, and 0.1 μM dexamethasone (all Sigma-Aldrich).
The culture medium was changed every 3 days for up
to 3 weeks. The adipogenic lineage cells were fixed in
10% formalin for 30 minutes and stained with Oil Red O
(Sigma-Aldrich), and the osteogenic lineage cells were
also fixed with 10% formalin for 30 minutes at room
temperature and stained with Alizarin red (pH 4.0;
Sigma-Aldrich) for 30 minutes. The stained cells were
observed under the microscope.
Detection of H2O2-induced apoptosis in vitro
hGSTM2-MSCs (2 × 105) were seeded in six-well plates
containing poly-L-lysine-coated slides. When the cells in
each well were 60 to 70% confluent, the medium in each
well was removed and replaced with fresh DMEM
medium with or without 0.5 mM H2O2, and the cells
were cultured for a further 6 hours. Apoptotic cells were
stained using an In Situ Cell Death Detection Kit (Roche,
Indianapolis, IN) and the cell nuclei were stained with
Vectashield mounting medium containing DAPI (Vector
Laboratories Inc, Burlingame, CA, USA). Apoptotic cells
were identified by their distinct condensed nuclei. Images
were acquired using a DFC420 microscope and Applica-
tion Suite Advanced Fluorescence software (Leica, Buffalo
Grove, IL, USA). pCDH-MSCs and untransduced MSCs
were used as controls.
Animal experiments
Animal experiments were performed in accordance with
the guidelines of the Institutional Animal Care and Use
Committee of the University of Texas Southwestern
Medical Center (UTSW), and were approved by the in-
stitutional ethics committee of UTSW.
To monitor the migration and localization of MSCs
in mouse kidney, three 129/svj mice were injected with
106 transduced MSCs via the tail vein, and renal sec-
tions were examined for GFP signal under fluorescence
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nal was also monitored in three mice injected with PBS
as controls.
The protective effect of hGSTM2-MSCs was evalu-
ated using the anti-GBM-GN mouse model as de-
scribed previously [17]. Briefly, 2-month-old 129/svj
mice (Jackson Laboratories, Bar Harbor, ME, USA)
were randomly divided into two groups of eight mice
each, and challenged with rabbit anti-mouse GBM
serum [18]. Two days after anti-GBM challenge, mice
were injected via the tail vein either with 106 hGSTM2-
MSCs (group 1) or 106 pCDH-MSCs (group 2). All
mice were housed at constant room temperature with
free access to water and food, and were observed for 3
weeks. Blood and urine samples were collected at days
0 (pretreatment), 14, and 21 of challenge, and assayed
for proteinuria and BUN. All mice were euthanized at
day 21, and tissues were collected and frozen at −80°C
for further analysis. Kidneys were removed and snap-
frozen in liquid nitrogen, or fixed in formaldehyde for
immunohistochemical analysis.
Western blotting analysis
Expression of hGSTM2 was assayed by western blotting
in cultured hGSTM2-MSCs and in the kidneys of
hGSTM2-MSC-injected mice. Proteins extracted from
cultured hGSTM2-MSCs or mouse kidneys were run in
4 to 10% SDS-PAGE gel, and transferred to PVDF
membranes. After blocking with 5% milk, the PVDF
was incubated with primary antibodies (rabbit anti-human
GSTM2 antibody, 1:800 dilution, rabbit anti-GAPDH anti-
body, 1:500 dilution; Santa Cruz Biotechnologies, Santa
Cruz, CA, USA) for 2 hours at room temperature and then
washed with PBS plus 0.1% Tween 20 (PBS-T) 3 times at 10
minutes each time. The membrane was further incubated
with goat anti-rabbit IgG HRP-conjugated secondary anti-
bodies (Thermal Scientific, Rockford, IL, USA) for 1 hour
followed by three washes with PBS-T. Chemiluminescence
was assayed with an Amersham ECL™ advance western
blotting detection kit (GE Healthcare Biosciences, Piscat-
away, NJ, USA). GAPDHwas used as an internal control.
Real-time RT-qPCR
Total RNA was extracted from cultured cells or mouse
renal tissue using an RNeasy kit (Qiagen) and reverse-
transcribed into cDNA with Superscript III using ran-
dom primer (Invitrogen). RT-qPCR were carried out
using TaqMan assays on a 7900 real-time PCR system
(Applied Biosystems, Foster City, CA, USA) with 5 μl
of 2 × TaqMan Universal PCR Master Mix, 4.5 μl of
cDNA, and 0.5 μl 20 × TaqMan Gene Expression Assay
Mix under the following thermal cycling conditions:
95°C for 10 minutes, followed by 40 cycles of 95°C for
15 seconds and 60°C for 1 minute. Each sample wasrun in triplicate. 18S rRNA (Hs03003631_g1) was used
as an internal control. The TaqMan assay identification
numbers of the genes measured are as follows: Bcl2
(Mm00477631_m1), CASP3 (Mm01195085_m1), CAT
(Mm00437992_m1), CCL2 (Mm00441242_m1), CCL5
(Mm01302428_m1), CCL7 (Mm00443113_m1), CCR5
(Mm01216171_m1), CD40lg (Mm00441911_m1), Fasl
(Mm00438864_m1), GPX1 (Mm00656767_g1), GSTM2
(Hs00265266_g1), IL-1β (Mm00434228_m1), IL-6 (Mm
99999064_m1), NFκB1 (Mm00476361_m1), TGF-β2
(Mm00436952_m1), and TNF (Mm00443258_m1).Measurement of proteinuria and BUN
Urine samples were collected for 24 hours from all the
experimental mice using metabolic cages with mice
allowed free access to water. Following the relevant
manufacturer’s instructions, urinary protein concentra-
tion was determined using a Coomassie Plus protein
assay kit (Thermo Fisher Scientific, Rockford, IL, USA),
while the serum BUN level was measured with a urea ni-
trogen kit (Sigma-Aldrich).Nitric oxide detection and antioxidase activity assay
NO level in kidney was quantified by QuantiChrom Nitric
Oxide Assay Kit (BioAassay Systems, Hayward, CA, USA).
Briefly, the kidney tissue was homogenized in PBS and
centrifuged at 10,000 × g at 4°C. The supernatant was
firstly deproteinized by treating with ZnSO4 and NaOH,
then 200 μl of working reagent was added to 100 μl of
sample and incubated at room temperature for 150 mi-
nutes. Finally, the optical density (OD) of each reaction
was read at 540 nm. NO level was calculated based on
a standard curve. SOD, and CAT activity in mouse kid-
ney tissue were measured using relevant kits (SOD
Assay Kit (Sigma-Aldrich) and Catalase Assay Kit (Cayman
Chemical Company, Ann Arbor, MI, USA), following each
manufacturer’s instructions.Kidney morphological and histological analysis
Renal tissues from mice were fixed in 10% formaldehyde,
dehydrated, embedded in paraffin wax, and sectioned.
Tissue sections were stained with periodic acid Schiff
(PAS), and examined in a blinded manner to evaluate
the degree of nephritis. The severity of GN was graded
on a scale of 0 to 4. The severity of tubulointerstitial
nephritis was also graded on a scale of 0 to 4, based on
the extent of tubular atrophy, inflammatory infiltrates,
and interstitial fibrosis, as detailed previously [12]. The
mesangial matrix accumulation was also evaluated by
PAS staining. Immunohistochemical staining was per-
formed to detect mesangial cell proliferation and mono-
cyte/macrophage infiltration with specific antibodies.
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sections
Apoptosis detection in kidney tissue sections was performed
with a DeadEnd™ Colorimetric Apoptosis Detection System
(Promega Corporation, Madison, WI, USA) in accordance
with the manufacturer’s instructions. TUNEL-positive
apoptotic cells were observed under light microscopy.
Renal immunohistochemical analysis
Immunohistochemical staining was performed on renal
sections as described previously [19]. Infiltration of
lymphocytes and macrophages was assayed by staining
with anti-CD3 antibody (1:200 dilution; Thermo Fisher
Scientific) and anti-Iba1 antibody (1:800 dilution; Abcam,
Cambridge, MA, USA), respectively. The number of CD3-
positive and Iba1-positive cells was calculated in 20 high
power fields (HPFs).
Levels of redox-related enzymes were also assayed by
immunohistochemical staining using the following anti-
bodies: anti-catalase (1:500; Sigma-Aldrich); anti-GPX1
(1:300) and anti-iNOS (1:200) (both Abcam). The kidney
slides were stained using a biotin-free immunoenzymatic
antigen detection system (Expose mouse/rabbit specific
HRP/DAB IHC kit, Abcam, USA). The intensity of im-
munohistochemical staining signal for CAT, GPX1 and
inducible nitric oxide synthase (iNOS) was evaluated
using the scales described previously [20], and the posi-
tive cells were counted in 20 HPFs.
Statistical analysis
Data were analyzed by standard statistical methods, and
Student’s t-test was used in statistical evaluation of the data
as appropriate using GraphPad Prism 5 (GraphPad Soft-
ware, Inc., La Jolla, CA, USA). Group data are expressed as
means ± SEM. Values of all parameters were considered
significantly different at a value of P<0.05.
Results
GSTM2 expression increased in the kidney of anti-GBM-
GN-resistant mice
Our previous studies showed that different mouse
strains had different sensitivity to anti-GBM-GN. NZW,
DBA1, and 129/svj mice, which were sensitive to anti-
GBM-GN, exhibited severe nephritis, whereas B6 and
BALB/c mice, which were relatively resistant to anti-
GBM-GN, had very mild nephritis [17]. Microarray gene
expression analysis was performed on the five mouse
strains (data are shown in the supplementary material;
see Additional file 1: Figure S1; see Additional file 2:
Table S1; see Additional file 3: Table S2). Comparing the
gene expression profile of the redox-related genes in the
kidneys of the different strains identified a group of
differentially expressed genes that clearly distinguished
between anti-GBM-GN-sensitive and anti-GBM-GN-resistant strains (Figure 1A). Of these genes, the GSTM2
gene was found to be significantly increased in B6 and
BALB/c mice compared with the three sensitive strains
(Figure 1A). The microarray data were further confirmed
by RT-qPCR assay (Figure 1B). GSTM2 is involved in
detoxification of ROS [13], and was selected for further
experiments in this study.
hGSTM2-MSCs expressed hGSTM2, and maintained the
differentiation property of MSCs
The human GSTM2 gene coding region was amplified
by PCR, and cloned into the MCSs of a lentiviral vector,
pCDH-MSCV-MCS-EF1-GFP-Puro (Figure 2A). The
recombinant viral particles, pCDH-hGSTM2, were puri-
fied from package cells and transduced into MSCs.
Untransduced MSCs had a fibroblast-like spindle shape
(Figure 2B). hGSTM2-transduced MSCs were GFP-positive
under fluorescence microscopy (Figure 2C). hGSTM2
expression was assayed by RT-qPCR and western blot-
ting; it was found only in hGSTM2-MSCs, and not in
pCDH-MSCs (Figure 2D, E).
The cell growth curve of MSCs, pCDH-MSCs, and
hGSTM2-MSCs is shown in Figure 3A; no significant
difference in cell proliferation was observed between
these three cell lines. The potential of MSCs to differenti-
ate into osteocytes and adipocytes was examined by cul-
turing the MSCs in appropriate induction medium. After
3 weeks of culture, the adipocytes were stained with Oil
Red O, and adipose droplets were visible (Figure 3B). In
the undifferentiated control groups, the cells maintained
their fibroblast-like shape without visible formation of
lipid droplets. For osteogenic differentiation, nodule-like
structures, which were stained with Alizarin red, were ob-
served after 3 weeks of induction, as shown in Figure 3C.
hGSTM2-MSCs were more resistant to H2O2-induced
apoptosis
The anti-oxidant effect of hGSTM2-MSCs was evaluated
for H2O2-induced apoptosis. Treatment with 0.5 mM
H2O2 for 6 hours induced a significant amount of apop-
tosis in MSCs and pCDH-MSCs (17% and 18% respect-
ively) (Figure 4A, B), whereas the number of apoptotic
cells in hGSTM2-MSCs was significantly reduced (11%,
P<0.05) (Figure 4C, D), indicating that hGSTM2-MSCs
were more resistant to H2O2-induced apoptosis.
hGSTM2-MSCs localized in mouse kidney and expressed
hGSTM2
We monitored the GFP signal of hGSTM2-MSCs; at 72
hours after tail vein injection, GFP-positive MSCs were
found to have migrated and localized in the kidney tubu-
lar interstitial region of recipient mice (Figure 5A, B).
Expression of hGSTM2 in mouse kidney was assayed by
RT-qPCR and western blotting; it was found in the
BA
Figure 1 Kidney gene expression profiling of five mice strains in an anti-glomerular basement membrane antibody-induced glomerulo-
nephritis (anti-GBM-GN) mouse model. (A) A group of oxidative stress-related genes that were differentially expressed between anti-GBM-GN-re-
sistant mouse strains (B6 and BALB/c) and anti-GBM-GN-sensitive strains (DBA1, 129/svj, and NZW). The GSTM2 gene was up-regulated in anti-GBM-GN-
resistant strains compared with anti-GBM-GN-sensitive strains. (B) Expression of glutathione S-transferase Mu 2 (GSTM2) in different mouse strains was
confirmed by reverse transcription quantitative PCR.
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MSC-injected mice (Figure 5C and 5D).
hGSTM2-MSCs attenuated anti-GBM-GN
The protective effect of hGSTM2-MSCs on anti-GBM-
GN was assessed in 129/svj mice. Before anti-GBMA
B C
Figure 2 Generation of human glutathione S-transferase Mu 2 mesench
expression. (A) Strategy of cloning the hGSTM2 gene into lentiviral vector pCD
(C) MSCs transduced with pCDH-hGSTM2. (D, E) Detection of hGSTM2 expressi
hGSTM2 expression was found only in MSCs transduced with pCDH-hGSTM2 achallenge, all mice had basal levels of proteinuria (1.52 ±
0.10 mg/24 hours) and BUN (7.80 ± 0.64 mg/dL). At day
14 after anti-GBM challenge, both pCDH-MSCs and
hGSTM2-MSCs injected mice exhibited dramatically in-
creased levels of proteinuria and BUN (Figure 6A and
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H-MSCV-MCS-EF1-GFP-Puro. (B) In vitro cultured MSCs before transduction.
on by (D) reverse transcription quantitative PCR and (E) Western blotting.

































Figure 3 Mesenchymal stem cells (MSCs) proliferation and differentiation characterization. (A) Cell proliferation analysis on MSCs,
pCDH-MSCs, and hGSTM2-MSCs. (B) The adipogenic differentiations of MSCs, pCDH-MSCs, and hGSTM2-MSCs were examined (at 21 days) with
Oil Red O staining. (C) The osteogenic differentiations of MSCs, pCDH-MSCs, and hGSTM2-MSCs were examined (at 21 days) with Alizarin red






















Figure 4 Human glutathione S-transferase Mu 2 mesenchymal stem cells (hGSTM2-MSCs) were resistant to hydrogen peroxide-induced
apoptosis. (A-C) Detection of apoptotic cells by terminal dUTP nick-end labeling (TUNEL) staining on in vitro cultured MSCs treated with 0.5 mM
H2O2 for 6 hours: representative images from (A) untransduced MSCs, (B) pCDH-MSCs (vector controls), and (C) hGSTM2-MSCs. (D) Quantitative
analysis of apoptotic cells showed that the percentage of apoptotic cells was significantly higher for MSCs and pCDH-MSCs than for
hGSTM2-MSCs (P<0.05).




























Figure 5 Human glutathione S-transferase Mu 2 mesenchymal stem cells (hGSTM2-MSCs) migrated to mouse kidney and expressed
hGSTM2. (A) Assay of renal tubular and interstitial region of 129/svj mice after intravenous injection of pCDH-MSCs (vector control) or
hGSTM2-MSCs. (B) Image of kidney from control mice receiving PBS injection. (C-D) Detection by (C) reverse transcription quantitative PCR and
(D) Western blotting of hGSTM2 expression in the kidney of mice receiving injection of pCDH-MSCs or hGSTM2-MSCs injection (n = 3 per group).
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uria (9.77 ± 0.82 mg/24 hours vs. 20.79 ± 1.35 mg/24
hours, a 53% reduction) and BUN (18.30 ± 2.19 mg/dL
vs. 28.20 ± 1.50 mg/dL, a 35% reduction) (P<0.05). At
day 21, the pCDH-MSC mice still had high levels of pro-
teinuria (20.01 ± 1.47 mg/24 hours) and BUN (40.40 ±
1.05 mg/dL), whereas the hGSTM2-MSC mice showed
further reduction in both proteinuria (8.35 ± 0.42 mg/24
hours) and BUN (16.70 ± 3.05 mg/dL), which were 59%
and 58% lower than that in pCDH-MSC group (P<0.05)
(Figure 6A, B). Histopathological analysis of kidney tis-
sue revealed significant glomerular proliferation and
crescent formation with GN score of 3.0 ± 0.4 in pCDH-
MSC-injected mice (Figure 6C, E), whereas hGSTM2-
MSC-injected mice exhibited significantly (P<0.05) less
severe pathological changes, with GN score 1.8 ± 0.3
(Figure 6D, 6E). These functional manifestation and
histological findings indicated that MSCs expressing
hGSTM2 attenuated anti-GBM autoantibody-induced
GN in 129/svj mice.
hGSTM2-MSCs inhibited anti-GBM-induced renal cell
apoptosis
Renal cell apoptosis was examined in kidney sections
from mice receiving hGSTM2-MSC or pCDH-MSC
transplantation. The percentage of renal apoptotic cells
was significantly lower in the hGSTM2-MSC group
(9.5% ± 0.5) compared with the pCDH-MSC group(17.5% ± 0.6) (P<0.05) (Figure 7A-C), indicating that
hGSTM2-MSCs attenuated renal cell apoptosis in anti-
GBM-GN. In addition, RT-qPCR showed that Bcl2 and
CD40lg were up-regulated in hGSTM2-MSC-treated
mice (Figure 8), which may have contributed to the anti-
apoptotic effect of hGSTM2-MSCs in mouse kidney.
hGSTM2-MSCs ameliorated inflammatory cell infiltration
Infiltration of macrophage and T lymphocytes in the renal
glomerular and interstential regions were assayed by im-
munohistochemical staining with anti-Iba1 and anti-CD3
antibodies. The number of infiltrated macrophages (Iba1-
positive) in hGSTM2-MSC-injected mice was significantly
less than in pCDH-MSC-injected control mice (25 ± 1 vs.
36 ± 2 cells per HPF, P<0.05) (Figure 9A-C). Similarly, the
infiltrated T lymphocytes (CD3-positive) were also lower
in hGSTM2-MSC-injected mice than in the pCDH-MSC-
injected control mice (14 ± 1 vs. 21 ± 1 cells per HPF,
P<0.05) (Figure 9D-F). hGSTM2-MSC treatment reduced
macrophage and T lymphocyte infiltration in renal tissues
by 31% and 33%, respectively, compared with pCDH-
MSC-treated controls.
hGSTM2-MSCs suppressed renal oxidative reaction
The effect of hGSTM2-MSCs against oxidative stress
was tested by measuring the renal expression level and/
or activity of oxidation-related products (iNOS, NO,
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Figure 6 Human glutathione S-transferase Mu 2 mesenchymal stem cells (hGSTM2-MSCs) attenuated anti-glomerular basement
membrane antibody-induced glomerulonephritis (anti-GBM-GN) in 129/svj mice. (A-B) Proteinuria and BUN were measured in 24-hour
urine samples on days 0, 14, and 21 in anti-GBM-challenged 129/svj mice injected with 1 × 106 pCDH-MSCs (vector controls) or the same
number of hGSTM2-MSCs. (C-D) Renal histological images from (C) pCDH-MSC-injected and (D) hGSTM2-MSC-injected 129/svj mice
challenged with anti-GBM antibody. Renal sections were stained with periodic acid Schriff (PAS). (C) Representative images of the kidney of
pCDH-MSC-injected mice, showing some of the typical light microscopic features seen in anti-GBM-induced nephritis in 129/svj mice,
including intracapillary hypercellularity, with obliteration of the capillary lumina, and tubular dilatation with casts. (D) Representative images of
the kidneys of the anti-GBM-GN mice injected with hGSTM2-MSCs, showing mild renal histological changes. (E) Renal pathology score of
anti-GBM-challenged 129/svj mice treated with pCDH-MSCs and hGSTM2-MSCs. Images are representative of sections from at least five mice
in each study group (original magnification ×400, scale bars = 50 μm).
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cells (14 ± 1 cells/HPF) and lower level of NO (19.61 ±
4.85 μM), which were approximately 39% and 66% lower
than that in pCDH-MSC-injected controls (23 ± 2 cells/
HPF and 57.25 ± 12.79 μM, respectively, P<0.05 in Figure
10A and 10D). By contrast, the renal activity of SOD was
significantly higher in hGSTM2-MSC-injected mice com-
pared with pCDH-MSC-injected controls (76.96 ± 3.93 vs.
59.52 ± 4.48, P<0.05 in Figure 10F). Furthermore, the
number of CAT-positive and GPX1-positive cells was
much higher in hGSTM2-MSC-injected mice (12 ± 1
cells/HPF and 13 ± 1 cells/HPF), compared with
pCDH-MSC-injected controls (5 ± 1 cells/HPF and 4 ±
1 cells/HPF, P<0.05 in Figure 10B and 10C). CAT activ-
ity was further confirmed to be significantly higher in
hGSTM2-MSC-injected mice compared with pCDH-
MSC-injected controls (19.28 ± 0.58 nmol/min/ml vs.
12.32 ± 1.43 nmol/min/ml, P<0.05 in Figure 10E).hGSTM2-MSCs inhibited inflammatory cytokines
The levels of inflammatory cytokines were measured by
RT-qPCR. As shown in Figure 8, the chemokine CCL2
and the cytokines IL-1β and IL-6 were decreased by 53%,
46%, and 52%, respectively, in hGSTM2-MSC-injected
mice compared with pCDH-MSC-injected controls
(P<0.05). Decreased expression of several other cytokines,
including CASP3, CCL5, CCL7, Fasl and TNF, was also
found in mice transplanted with hGSTM2-MSCs, al-
though this was not statistically significant compared with
controls (data not shown).
Discussion
It is well known that inflammatory cytokines and che-
mokines are involved in the pathogenesis of immune-
mediated nephritis [21,22]. Immune-mediated nephritis
is an autoimmune and inflammatory process involving
immune cell infiltration and expression of inflammatory
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Figure 8 Detection of cytokines, apoptotic factors and antioxidase genes by reverse transcription quantitative PCR (RT-qPCR) in
anti-glomerular basement membrane antibody-induced glomerulonephritis (anti-GBM-GN) mice. Expression of seven genes representing
proinflammatory cytokines and apoptosis factors in the kidneys were measured by RT-qPCR on 129 mice treated with hGSTM2-MSCs or
pCDH-MSCs (vector control). 18rRNA was used as internal control. Relative quantity (RQ) in each bar represents the mean of five samples. Error
bars denote SEM.
Figure 7 Human glutathione S-transferase Mu 2 mesenchymal stem cells (hGSTM2-MSCs) inhibited renal cell apoptosis in
anti-glomerular basement membrane antibody-induced glomerulonephritis (anti-GBM-GN) mice. Terminal dUTP nick-end labeling (TUNEL)
staining using DeadEnd™ Colorimetric Apoptosis Detection System to show apoptotic cells in renal sections of 129/svj with anti-GBM-GN injected
with (A) pCDH-MSCs (vector control) or (B) hGSTM2-MSCs. Cells with brown nuclei are apoptotic cells (indicated by arrow). (C) Quantitative
analysis of apoptotic cells expressed as a percentage of total cell number. Images were representative of sections from at least five mice in each
study group (original magnification ×400, scale bars = 50 μm).
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Figure 9 Human glutathione S-transferase Mu 2 mesenchymal stem cells (hGSTM2-MSCs) suppressed renal inflammatory cell infiltration in
mouse kidney. 129/svj mice with anti-glomerular basement membrane antibody-induced glomerulonephritis (anti-GBM-GN) were injected with
hGSTM2-MSCs or pCDH-MSCs (vector control) for 21 days, and renal inflammatory cell infiltration was analyzed by immunohistochemical analysis
staining with anti-Iba1 (macrophages) and anti-CD3 (T lymphocytes). (A, B) Anti-Iba1 staining for macrophage infiltration in (A) pCDH-MSC-treated
and (B) hGSTM2-MSC-treated mice. (C) Quantitative analysis of Iba1-positive cells expressed as cell numbers per high power field (P<0.05). (D-E) Anti-CD3
staining for T lymphocyte infiltration in (D) pCDH-MSC-treated and (E) hGSTM2-MSC-treated mice. (F) Quantitative analysis of CD3-positive cells expressed
as cell numbers per high power field (P<0.05). Original magnification ×400, scale bars = 50 μm.
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tion, the activated inflammatory reaction leads to the
generation of oxidative radicals, such as H2O2 and ROS,
and accumulation of these radicals will cause tissue
damage. Excessive ROS can disturb redox status, result-
ing in damage to macromolecules, and can modulate the
expression of a variety of immune and inflammatory
molecules, further exacerbating inflammation and indu-
cing tissue damage [27]. Further studies have shown the
presence of increased oxidative stress in chronic kidney
disease [28-30]. These observations implicate the rela-
tionship between ROS and chemotactic cytokine pro-
duction in autoimmune disease.
In the study, using the anti-GBM-GN mouse model,
we found that the increased sensitivity of 129/svj mice
to anti-GBM antibody-induced renal damage may be
related to impaired production of the anti-oxidant mol-
ecule GSTM2 in inflamed renal tubules. Therefore, we
postulated that manipulating the expression of GSTM2 in
mouse kidney might be able to combat the renal injury
caused by anti-GBM antibodies.
In order to target GSTM2 expression in inflamed kid-
neys, we chose to use genetically modified MSCs asvehicles. MSCs have been shown to be a promising
approach for targeted gene delivery because of their
potential to migrate to the injured renal tissue and
differentiate into intrinsic kidney cells [31,32]. Genetic-
ally modified MSCs have been used to carry kallikrein
(KLK), HO-1 and PEDF genes, which showed increased
protective effect against acute ischemic kidney injury,
osteoporosis, and hepatocellular carcinoma, respectively
[33-35]. We recently further proved that KLK-transduced
MSCs exhibited enhanced protective effect against anti-
GBM-GN and lupus nephritis [36]. The molecular pathways
underlining the protective effect of KLK in anti-GBM-
GN is not yet fully understood, but the close correlation
between the levels of KLK and GSTM2 in the renal tissue
of anti-GBM-GN mice implies that GSTM2 might be
one of the effector molecules involved in ameliorating
inflammation and oxidative stress during the course of
autoantibody-induced nephritis [17,18,36,37].
In the current study, we used lentiviral vector, an effi-
cient and safe retroviral vector system to transduce the
human GSTM2 gene into mouse MSC genome. This
vector carries GFP and a drug-resistant selection marker,
which facilitate the cloning process. Furthermore, we
Figure 10 Human glutathione S-transferase Mu 2 mesenchymal stem cells (hGSTM2-MSCs) suppressed renal oxidative reaction.
Immunohistochemical assay on cells positive for inducible nitric oxide synthase (iNOS), catalase (CAT) or glutathione peroxidase 1 (GPX1) in renal
slides. (A) hGSTM2-MSC treatment significantly reduced the number of iNOS-positive cells compared with pCDH-MSC (vector) treatment. (B-C) The
numbers of CAT-positive and GPX1-positive cells were significantly higher in hGSTM2-MSC-treated mice compared with control mice. (D) Nitric oxide
(NO) level in the kidneys of mice treated with pCDH-MSCs and hGSTM2-MSCs. NO was reduced in the kidneys of hGSTM2-MSC-treated mice
compared with pCDH-MSC-treated mice (P<0.05). (E) CAT and (F) superoxide dismutase (SOD) activities were significantly increased in the kidneys
of hGSTM2-MSC-treated mice compared with pCDH-MSC-treated mice (P<0.05).
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easy monitoring of hGSTM2 expression in mouse tis-
sues. The stable cell line, hGSTM2-MSC, not only
expressed high levels of hGSTM2, but also retained the
differentiation properties of MSCs. After transplantation
into 129/svj mice, the hGMTM2-MSCs migrated to the
kidney and expressed high levels of hGSTM2 locally.
We tested the anti-oxidant effect of hGSTM2 in vitro
by H2O2 stimulation assay. The data showed that
hGSTM2-transduced MSCs (hGSTM2-MSCs) were more
resistant to H2O2-induced apoptosis compared with
vector-transduced MSCs (pCDH-MSCs). A similar effect
was observed in vivo in mouse kidneys. The hGSTM2-
MSC-injected mice exhibited much less renal cell apoptosis
than the pCDH-MSC-treated controls. The anti-apoptotic
effect of GSTM2 is possibly attributable to its ability to
erase oxidative radicals by detoxifying ROS and super-
oxide [13]. It was reported that GSTM2 could inhibit
oxidative damage and inflammation [13-16], and it was
shown that ROS is a source of cell stress and apoptosis
[8]. hGSTM2-MSC injection inhibited the activity ofrenal iNOS, which is a major source of reactive oxidant
stress in murine models of lupus nephritis [38]. We ob-
served that the expression of GSTM2 in hGSTM2-
MSC-treated mice was accompanied by over-expression
of CAT and GPX1, which are both potential scavengers
of free oxidative radicals. The anti-apoptotic effects of
the oxidation-resistant genes may be related to the in-
crease in anti-apoptotic molecules such as Bcl2 and
CD40lg [39,40], which were significantly up-regulated
in hGSTM2-MSC-treated mouse kidneys.
The main function of GSTs involves cellular detoxifi-
cation, and this detoxification process is a critical cellu-
lar defense mechanism, which can protect the cell
against a series of toxic and chemical substances [41].
Although normal cells can deal with oxidative stress
through intact anti-oxidative systems, GSTs and GPXs
prevent the cells from further oxidative damage [42]. If
the oxidative stress exceeds a defendable level or if
there is a dysfunction of the cellular anti-oxidative sys-
tem, the exogenous and endogenous oxidative stresses
will cause oxidative damage to tissue. The ability to
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tial for the survival of all organisms, thus disruption of
these redox circuits will cause oxidative stress, and even
oxidative damage.
A reduction in the activity of CAT in serum was found
in anti-GBM-GN, and a significant decrease in the activ-
ity of GPX was observed in patients with systemic lupus
erythematosus (SLE) [19,26]. A change in redox ratio is
a significant parameter for oxidative stress and such as
change in favor of oxidized glutathione is observed in
autoimmune disease. The levels of glutathione correlate
negatively with disease activity in SLE. Low levels of
glutathione have also been found in the majority of
patients with SLE patients who have nephritis [26]. It
has been suggested that the reduced activities of CAT and
GPX in nephritis could be due to the inactivation of the
enzymes by over-generation of H2O2 [43]. GPX1 is one of
the main cytosolic isoforms in mammalian cells, and plays
a crucial role in the protection of cells against oxidative
damage by H2O2 [44]. GPXs, as major anti-oxidative dam-
age enzymes, can protect cells against oxidative damage
[45]. The primary role of GST is the metabolism of a
broad range of ROS, and it thus plays an important role
in cellular resistance against oxidative stress [46].
Oxidative stress and inflammation are two closely re-
lated pathological processes in immune-mediated tissue
damage [26,47,48]. Deposition of autoantibody and/or im-
mune complex can initiate a local immune response in-
volving complement activation, immune cell infiltration,
and inflammatory cytokine secretion. The inflammation
process that recruits T cells, B cells, macrophages, and
neutrophils to the inflammatory sites could generate ex-
cessive free ROS and superoxide, which will then acceler-
ate the immunological damage in lupus nephritis. In this
report, we observed that hGSTM2-MSCs suppressed the
expression of inflammatory cytokines, and inhibited infil-
tration of lymphocytes and macrophages in renal tissues,
further confirming that suppression of oxidative stress can
ameliorate inflammatory damage.
Previous experiments have shown that MSCs them-
selves might be a therapeutic source for treatment of
immune-related renal disease including lupus nephritis
[49,50]. Our data indicate that transducing MSCs with
therapeutic genes could significantly enhance their effect
on anti-GBM-GN and lupus nephritis [36]. This study
provides further evidence that MSCs could be used as
vehicles to deliver potential therapeutic molecules to tar-
get tissues, and therefore may have an added beneficial
effect on immune-medicated renal disease.
We plan to perform further experiments to evaluate
the protective effect of hGSTM2-MSCs on lupus neph-
ritis and diabetic nephritis, as both diseases show
chronic renal inflammation. Further experiments should
also be conducted to evaluate the distribution andexpression of target gene in other tissues, and the long-
term effect of transplanted cells, before they are trialed
for treatment of human diseases.
Conclusions
GSTM2 might be an important player in combating
anti-GBM-GN. hGSTM2-MSCs suppressed the expres-
sion of inflammatory cytokines and inhibited infiltration
of lymphocytes and macrophages in renal tissues, which
may have contributed to the suppression of oxidative
stress and amelioration of inflammatory damage. Thus,
GSTM2-transduced MSCs may be a potential thera-
peutic agent for immune-mediated nephritis.
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